2 results
424B5
NBSE
NeuBase Therapeutics Inc
6 Feb 15
Prospectus supplement for primary offering
12:00am
corporate purpose is solely to invest in securities or otherwise in circumstances which do not require the publication by us of a prospectus pursuant
424B5
NBSE
NeuBase Therapeutics Inc
5 Feb 15
Prospectus supplement for primary offering
12:00am
or regulated, whose corporate purpose is solely to invest in securities or otherwise in circumstances which do not require the publication by us
- Prev
- 1
- Next